Antioxidant Enzyme Regulation Chonluten For Sale

Overview: Antioxidant Enzyme Regulation and Chonluten in Research

Chonluten (Glu-Asp-Gly / EDG) is a synthetic short bioregulatory tripeptide evaluated in preclinical models for its ability to modulate endogenous antioxidant enzyme regulation. Research models indicate that Chonluten interacts with genomic regulatory sequences to upregulate key cellular defenses, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), particularly within pulmonary and bronchial tissue preparations.

In cell culture and animal models, oxidative stress generated by reactive oxygen species (ROS) leads to lipid peroxidation, protein oxidation, and DNA strand breaks. Investigating small regulatory molecules capable of restoring homeostatic enzyme expression represents a primary focus in contemporary redox biology. Investigators purchasing Chonluten for research utilize the peptide to examine chromatin remodeling, nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation, and downstream free radical neutralization mechanisms in controlled laboratory environments.

To ensure precise, reproducible experimental data, laboratory personnel require ultra-pure reagents free from lipopolysaccharide (LPS) contamination or truncated peptide sequences. PX1 Research delivers analytical-grade compounds synthesized in GMP-compliant facilities within the United States, backed by independent ISO 17025 laboratory verification.

Molecular Architecture and Physicochemical Properties of Chonluten

Chonluten is a short synthetic peptide comprising three amino acid residues: L-glutamic acid, L-aspartic acid, and glycine (H-Glu-Asp-Gly-OH). With a low molecular mass, this tripeptide exhibits high water solubility and favorable tissue diffusion characteristics in ex vivo and in vitro research systems.

Short peptide bioregulators operate differently than large globular proteins or complex growth factors. Due to their minimal molecular footprint, tripeptides like Chonluten can penetrate cellular membranes and interact directly with nucleosomes or specific promoter regions of DNA. In structural biology experiments, the negatively charged side chains of glutamic and aspartic acid residues facilitate ionic interactions with histones and specific DNA motifs.

Researchers evaluating structural analogs can reference our detailed technical guides in the PX1 Research Library, which explore how tripeptide conformations influence target affinity and transcriptomic modulation across diverse tissue models.

Mechanistic Insights: Nrf2 Pathways and Transcriptional Activation

The primary mechanism under investigation regarding Chonluten centers on its role in transcriptionally regulating cellular defense systems. Preclinical studies suggest that short peptide bioregulators promote the expression of endogenous antioxidant enzymes by modulating signal transduction pathways, specifically the Kelch-like ECH-associated protein 1 (Keap1) and Nrf2 axis.

Under baseline conditions, Keap1 targets Nrf2 for ubiquitin-mediated proteasomal degradation. Upon exposure to redox-active compounds or regulatory peptides, Nrf2 dissociates from Keap1, translocates to the nucleus, and binds to Antioxidant Response Elements (ARE) in the promoter regions of target genes. Quantitative reverse transcription PCR (RT-qPCR) assays in alveolar epithelial cell lines demonstrate elevated mRNA levels for SOD1, SOD2, Catalase, and Hemoxygenase-1 (HO-1) following treatment with short peptides.

Understanding these downstream transcriptional changes allows scientists to map cell survival kinetics under hyperoxic or hydrogen peroxide-induced stress conditions. For complementary studies on pathway-specific peptide signaling, explore our analysis on Nrf2 pathway antioxidant peptides.

Preclinical Findings: Bronchopulmonary and Epithelial Cell Models

In vitro data indicate that Chonluten exhibits marked tissue-specificity toward bronchial and alveolar epithelial structures. Primary human bronchial epithelial cells (PBECs) and immortalized cell lines (such as A549) treated with Chonluten show altered expression profiles for structural cytokeratins and tight junction proteins alongside increased antioxidant capacity.

In animal models of acute lung injury (ALI) and toxic smoke inhalation, administration of synthetic Chonluten reduced markers of lipid peroxidation, such as malondialdehyde (MDA), while preserving systemic SOD and GPx enzyme activities. Rodent histopathological evaluations revealed reduced neutrophil infiltration and decreased inflammatory cytokine expression (TNF-alpha, IL-6) within alveolar spaces.

These findings demonstrate that antioxidant enzyme regulation by short bioregulators is tightly coupled with structural tissue preservation under simulated oxidative challenges. Investigators conducting comparative lung tissue studies can select specialized compounds from our full research peptide catalog.

Comparative Analysis: Short Peptide Bioregulators in Redox Research

Chonluten belongs to a class of short bioregulatory peptides derived from tissue-specific peptide complex research pioneered by the Khavinson Institute. To select the appropriate molecule for specific laboratory protocols, researchers often compare Chonluten against related tripeptides and short chains targeting distinct tissue systems.

While Chonluten specifically targets respiratory epithelial cells and pulmonary antioxidant defenses, Bronchogen (Ala-Glu-Asp-Leu) is frequently evaluated alongside it to compare transcriptomic profiles in bronchial tissue repair. Similarly, Vesugen (Lys-Glu-Asp) targets vascular endothelial cell integrity and nitric oxide synthase pathways, whereas Cartalax (Ala-Glu-Asp-Gly) is utilized in connective tissue and chondrocyte extracellular matrix assays. Reviewing these structural variations helps laboratory teams isolate tissue-specific regulatory pathways versus broad-spectrum antioxidant effects.

For a broader overview of how short peptide sequences regulate cellular aging and gene expression across multiple tissue lineages, refer to our comprehensive guide on tripeptide bioregulators overview.

Reconstitution, Solubility, and Storage Protocols for Laboratory Use

Proper handling and preparation of synthetic tripeptides are critical to maintaining structural integrity and experimental repeatability. Chonluten is supplied as a lyophilized white powder under sterile vacuum or inert gas flushing.

Reconstitution should be performed using sterile, bacteriostatic water or laboratory-grade Phosphate-Buffered Saline (PBS, pH 7.4). Due to its hydrophilic amino acid composition (Glu-Asp-Gly), Chonluten dissolves readily without requiring harsh organic solvents like DMSO. After reconstitution, gentle agitation is recommended; high-shear vortexing should be avoided to prevent peptide aggregation.

For short-term experimental series (1–7 days), reconstituted stock solutions may be stored at 2°C to 8°C. For long-term preservation, stock aliquots must be frozen at -20°C or -80°C to prevent hydrolysis and enzymatic degradation. Repeated freeze-thaw cycles should be avoided by preparing single-use aliquots prior to initial freezing.

Analytical Verification: Third-Party COA, HPLC, and Endotoxin Standards

When purchasing compounds for antioxidant enzyme regulation studies, analytical purity is non-negotiable. Contaminants such as residual TFA (trifluoroacetic acid), heavy metals, or endotoxins can induce non-specific cellular responses, invalidating assay control groups.

PX1 Research enforces strict quality control standards for every lot of Chonluten synthesized. Every batch undergoes rigorous testing at independent, ISO 17025 accredited analytical laboratories in the United States:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity exceeding 98.0%, verifying the absence of truncated or modified peptide side-products. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact theoretical molecular weight and sequence identity. 3. Bacterial Endotoxin Testing (LAL Assay): Verifies endotoxin levels remain strictly under <0.01 EU/mg, preventing lipopolysaccharide-induced inflammatory artifacts in cell culture assays.

Complete, lot-specific Certificates of Analysis (COAs) are accessible directly on our platform, ensuring transparent data verification before purchasing.

Laboratory Procurement: Ordering High-Purity Chonluten from PX1 Research

PX1 Research simplifies raw material sourcing for academic institutions, biotechnology firms, and independent research organizations. All compounds are manufactured in domestic, GMP-compliant facilities and shipped directly from our primary distribution hubs in California and Arizona.

Orders placed before 12:00 PM PST (Monday through Friday) ship same-day via expedited cold-chain compliant logistics, minimizing transit time and thermal exposure. Whether your protocol requires milligram-scale screening quantities or bulk gram-scale lots for high-throughput assays, PX1 provides consistent batch-to-batch reproducibility.

Principal investigators and laboratory managers setting up recurring supply channels or institutional accounts can apply for custom enterprise terms through our wholesale peptide program.